down arrow

Zura Bio Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG9TY5A1016
USD
4.27
0.00 (0.00%)

Dec 19

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4.204.33

52 Week

0.974.68
Valuation
Technical
Day's Volume

CASH

288.19 k

Shareholding (Mar 2025)

FII

1.58%

Held by 19 FIIs

DII

79.04%

Held by 12 DIIs

Promoter

12.24%

How big is Zura Bio Ltd.?

22-Jun-2025

As of Jun 18, Zura Bio Ltd. has a market capitalization of 70.54 million, with net sales of 0.00 million and a net profit of -62.10 million over the latest four quarters. As of Dec 24, shareholder's funds are at 146.81 million and total assets at 179.53 million.

As of Jun 18, Zura Bio Ltd. has a market capitalization of 70.54 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -62.10 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 146.81 million and Total Assets at 179.53 million.

Read More

What does Zura Bio Ltd. do?

22-Jun-2025

Zura Bio Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $17 million and a market cap of $70.54 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -41.58%.

Overview: <BR>Zura Bio Ltd. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -17 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 70.54 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.23 <BR>Return on Equity: -41.58% <BR>Price to Book: 0.51<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Zura Bio Ltd. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Zura Bio Ltd. shows a mildly bullish trend supported by positive MACD and moving averages, despite mixed signals from Bollinger Bands and KST, while outperforming the S&P 500 recently but underperforming over the past year and three years.

As of 9 September 2025, the technical trend for Zura Bio Ltd. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages also indicate a bullish stance. However, the Bollinger Bands show a mildly bearish trend on the monthly timeframe, and the KST is bearish on the monthly while bullish on the weekly. The Dow Theory supports a mildly bullish outlook on both weekly and monthly timeframes. <BR><BR>In terms of returns, Zura Bio Ltd. has outperformed the S&P 500 over the past week and month, with returns of 1.49% and 17.82% respectively, but has significantly underperformed over the year and three years, with returns of -50.36% and -79.56%. Overall, the current technical stance is mildly bullish, driven by the positive signals from MACD and moving averages, despite some mixed indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 144 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.23

stock-summary
Return on Equity

-50.75%

stock-summary
Price to Book

1.14

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-16 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
114.57%
0%
114.57%
6 Months
284.68%
0%
284.68%
1 Year
82.48%
0%
82.48%
2 Years
-14.6%
0%
-14.6%
3 Years
-58.14%
0%
-58.14%
4 Years
-56.65%
0%
-56.65%
5 Years
0%
0%
0.0%

Zura Bio Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-480.26%
EBIT to Interest (avg)
-43.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.23
Sales to Capital Employed (avg)
0.56
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
77.40%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.56
EV to EBIT
1.40
EV to EBITDA
1.40
EV to Capital Employed
2.86
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
204.10%
ROE (Latest)
-41.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 20 Schemes (7.14%)

Foreign Institutions

Held by 19 Foreign Institutions (1.58%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -55.34% vs 69.71% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.10",
          "val2": "-11.80",
          "chgp": "-53.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.00",
          "val2": "-10.30",
          "chgp": "-55.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.53% vs -121.98% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-55.20",
          "val2": "-62.60",
          "chgp": "11.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.20",
          "val2": "-1.50",
          "chgp": "-246.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-52.40",
          "val2": "-60.60",
          "chgp": "13.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-18.10
-11.80
-53.39%
Interest
0.00
0.00
Exceptional Items
0.00
-0.80
100.00%
Consolidate Net Profit
-16.00
-10.30
-55.34%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -55.34% vs 69.71% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-55.20
-62.60
11.82%
Interest
0.00
0.00
Exceptional Items
-5.20
-1.50
-246.67%
Consolidate Net Profit
-52.40
-60.60
13.53%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 13.53% vs -121.98% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Zura Bio Ltd. stock-summary
stock-summary
Zura Bio Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."